Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs
1 other identifier
interventional
55
0 countries
N/A
Brief Summary
The purpose of this study is to compare the performances of 2 bifocal IOLs and 1 trifocal IOL for far, near and intermediate vision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 6, 2016
CompletedFirst Posted
Study publicly available on registry
December 13, 2016
CompletedSeptember 6, 2018
September 1, 2018
3.1 years
December 6, 2016
September 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Intermediate visual acuity
12 months
Secondary Outcomes (2)
Distance visual acuity
12 months
Near visual acuity
12 months
Study Arms (3)
809M
ACTIVE COMPARATORbifocal intraocular lens (IOL)
839MP
ACTIVE COMPARATORtrifocal intraocular lens (IOL)
SN6AD1
ACTIVE COMPARATORbifocal intraocular lens (IOL)
Interventions
Eligibility Criteria
You may qualify if:
- Patients of any gender, aged 50 to 80 years
- Signed informed consent form
- Healthy eyes besides cataract
- Assured follow-up examinations
- Stable corneal conditions within the last 12 months
- Corneal astigmatism less than 1D
- Implantation into the capsular bag by injector
You may not qualify if:
- Degenerative visual disorders (e.g. macular degeneration, optic nerve atrophy, or retinal disorders)
- Pseudophakia
- Cornea guttata; keratoplasty
- Irregular astigmatism (e.g. Keratoconus)
- Corneal scarring
- Diabetic retinopathy
- Aniridia
- Amblyopia
- Amotio operation; anamnesis with vitreous surgery
- Pseudoexfoliation Syndrome; Uveitis
- Previous intraocular and corneal surgery
- Intraocular tumours; endotamponade
- Glaucoma or IOP higher than 24mmHg
- Phlogistic intraocular processes or other pre-existing processes that permanently limit the best corrected visual acuity to \> 0.3 logMAR
- Need for a dioptre out of the range of +16.0D to +26.0D
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2016
First Posted
December 13, 2016
Study Start
March 1, 2012
Primary Completion
April 1, 2015
Study Completion
October 1, 2015
Last Updated
September 6, 2018
Record last verified: 2018-09